Here is an article about the TME Pharma news, written in a polite tone with relevant information:
TME Pharma Announces Termination of Liquidity Contract
Paris, France – July 8, 2025 – TME Pharma N.V. announced today the termination of its liquidity contract. The decision, effective as of the close of trading on July 7, 2025, signifies a change in the company’s financial arrangements concerning the trading of its shares.
The liquidity contract, previously managed by Invest Corporate Finance, was established to facilitate orderly trading and ensure the availability of shares in the market. The termination of this agreement means that the dedicated market-making services provided under the contract will cease.
While the specific reasons for the termination were not detailed in the announcement, such decisions are typically made by companies for a variety of strategic, financial, or operational considerations. It is important for investors to understand that the absence of a liquidity contract may potentially impact the volatility and bid-ask spread of TME Pharma’s shares in the near term, although the company itself remains listed and traded on the stock exchange.
TME Pharma continues its operations and remains focused on its core business activities and strategic objectives. Investors are encouraged to consult official company communications and market data for the most up-to-date information regarding the company’s performance and share trading.
TME Pharma : RÉSILIATION DU CONTRAT DE LIQUIDITÉ
AI has delivered the news.
The answer to the following question is obtained from Google Gemini.
Business Wire French Language News published ‘TME Pharma : RÉSILIATION DU CONTRAT DE LIQUIDITÉ’ at 2025-07-08 06:00. Please write a detailed article about this news in a polite tone with relevant information. Please reply in English with the article only.